Ameriprise’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,109,851
| Closed | -$10.2M | – | 4004 |
|
|
2021
Q2 | $10.2M | Sell |
1,109,851
-890,083
| -45% | -$8.16M | ﹤0.01% | 1932 |
|
|
2021
Q1 | $9.9M | Buy |
1,999,934
+13,776
| +0.7% | +$68.2K | ﹤0.01% | 1895 |
|
|
2020
Q4 | $8.62M | Sell |
1,986,158
-5,345
| -0.3% | -$23.2K | ﹤0.01% | 1854 |
|
|
2020
Q3 | $8.54M | Buy |
1,991,503
+30,214
| +2% | +$130K | ﹤0.01% | 1664 |
|
|
2020
Q2 | $8.75M | Buy |
1,961,289
+843,456
| +75% | +$3.76M | ﹤0.01% | 1632 |
|
|
2020
Q1 | $4.46M | Buy |
1,117,833
+72,945
| +7% | +$291K | ﹤0.01% | 1981 |
|
|
2019
Q4 | $8.83M | Buy |
1,044,888
+270
| +0% | +$2.28K | ﹤0.01% | 1846 |
|
|
2019
Q3 | $7.16M | Buy |
1,044,618
+620,418
| +146% | +$4.25M | ﹤0.01% | 1955 |
|
|
2019
Q2 | $3.53M | Buy |
+424,200
| New | +$3.53M | ﹤0.01% | 2442 |
|